NO994220L - Ekspresjonskloningsmetoder for oppdagelse, karakterisering og isolering av gener som koder for polypeptider med en på forhÕnd bestemt egenskap - Google Patents

Ekspresjonskloningsmetoder for oppdagelse, karakterisering og isolering av gener som koder for polypeptider med en på forhÕnd bestemt egenskap

Info

Publication number
NO994220L
NO994220L NO994220A NO994220A NO994220L NO 994220 L NO994220 L NO 994220L NO 994220 A NO994220 A NO 994220A NO 994220 A NO994220 A NO 994220A NO 994220 L NO994220 L NO 994220L
Authority
NO
Norway
Prior art keywords
characterization
isolation
proteins
discovery
glycoproteins
Prior art date
Application number
NO994220A
Other languages
English (en)
Norwegian (no)
Other versions
NO994220D0 (no
Inventor
James E Bailey
Wolfgang A Renner
Georg H Orberger
Daniel Koller
Original Assignee
Cytos Biotechnology Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytos Biotechnology Gmbh filed Critical Cytos Biotechnology Gmbh
Publication of NO994220D0 publication Critical patent/NO994220D0/no
Publication of NO994220L publication Critical patent/NO994220L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/912—Absidia

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
NO994220A 1997-11-17 1999-08-31 Ekspresjonskloningsmetoder for oppdagelse, karakterisering og isolering av gener som koder for polypeptider med en på forhÕnd bestemt egenskap NO994220L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/972,218 US6197502B1 (en) 1997-11-17 1997-11-17 Expression cloning processes for the discovery characterization, and isolation of genes encoding polypeptides with a predetermined property
PCT/US1998/024520 WO1999025876A1 (en) 1997-11-17 1998-11-17 Expression cloning processes for the discovery, characterization and isolation of genes encoding polypeptides with a predetermined property

Publications (2)

Publication Number Publication Date
NO994220D0 NO994220D0 (no) 1999-08-31
NO994220L true NO994220L (no) 1999-09-27

Family

ID=25519360

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994220A NO994220L (no) 1997-11-17 1999-08-31 Ekspresjonskloningsmetoder for oppdagelse, karakterisering og isolering av gener som koder for polypeptider med en på forhÕnd bestemt egenskap

Country Status (11)

Country Link
US (2) US6197502B1 (de)
EP (1) EP0972086B1 (de)
AT (1) ATE407219T1 (de)
AU (1) AU760584B2 (de)
CA (1) CA2282811A1 (de)
DE (1) DE69839962D1 (de)
EA (1) EA199900668A1 (de)
IL (1) IL131759A0 (de)
NO (1) NO994220L (de)
NZ (1) NZ337297A (de)
WO (1) WO1999025876A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413776B1 (en) 1998-06-12 2002-07-02 Galapagos Geonomics N.V. High throughput screening of gene function using adenoviral libraries for functional genomics applications
US6783939B2 (en) * 2000-07-07 2004-08-31 Alphavax, Inc. Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
DE10040289A1 (de) * 2000-08-17 2002-02-28 Aventis Res & Tech Gmbh & Co Verfahren zur Herstellung und Ermittlung geeigneter Effektoren von Zielmolekülen mit Substanzbibliotheken
US6830885B1 (en) 2000-08-18 2004-12-14 Phenogene Therapeutiques Inc. Nucleic acid molecule, method and kit for selecting a nucleic acid having a desired feature
US20030170642A1 (en) * 2001-03-12 2003-09-11 Irm, Llc Identification of cellular targets for biologically active molecules
WO2002095654A1 (en) * 2001-05-22 2002-11-28 Entelos, Inc. Methods for predicting the activities of cellular constituents
WO2003023026A1 (en) * 2001-09-06 2003-03-20 Alphavax, Inc. Alphavirus replicon vector systems
US20040152105A1 (en) * 2002-09-06 2004-08-05 Cytos Biotechnology Ag. Immune modulatory compounds and methods
AU2003297039B2 (en) * 2002-12-13 2009-03-05 Alphavax, Inc. Multi-antigenic alphavirus replicon particles and methods
AU2003297041B2 (en) * 2002-12-13 2009-02-26 Alphavax, Inc. Alphavirus particles and methods for preparation
EP1608762B1 (de) * 2003-03-20 2014-01-08 Alphavax, Inc. Verbesserte alphavirus replikons und helferkonstrukt
PT1651666E (pt) * 2003-07-11 2009-08-28 Alphavax Inc Vacinas de citomegalovírus à base de alfavírus
PT1751289E (pt) 2004-05-18 2009-03-31 Alphavax Inc Vectores de alfavirais derivados da tc-83, partículas e métodos
US7303898B2 (en) * 2005-03-29 2007-12-04 New York University Defective sindbis viral vectors
JP5225087B2 (ja) 2005-08-24 2013-07-03 ザ スクリプス リサーチ インスティチュート 翻訳エンハンサーエレメント依存性のベクター系
DK2947149T3 (en) 2007-06-21 2018-06-06 Alphavax Inc ALPHAVIRUS REPLICATION PARTICLES FOR USE IN VACCINATION
WO2009079185A2 (en) * 2007-11-26 2009-06-25 Novartis Vaccines And Diagnostics, Inc. Methods of generating alphavirus particles
EP2065398A1 (de) 2007-11-29 2009-06-03 Cytos Biotechnology AG Humane, monoklonale, nikotinspezifische Antikörper
WO2009068335A1 (en) 2007-11-29 2009-06-04 Cytos Biotechnology Ag Human monoclonal nicotine specific antibodies
SG10201408164XA (en) * 2007-12-11 2015-01-29 Scripps Research Inst Compositions and methods related to mrna translational enhancer elements
WO2010005704A2 (en) * 2008-06-13 2010-01-14 New York University Novel helper plasmid, defective sindbis viral vectors and methods of use thereof
WO2010063675A1 (en) 2008-12-04 2010-06-10 Cytos Biotechnology Ag Fully human influenza m2 specific antibodies
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
CN107254488A (zh) * 2017-05-27 2017-10-17 上海市农业科学院 一种辛德毕斯病毒全长质粒型载体及其构建方法
AU2024208643A1 (en) 2023-01-12 2025-06-26 Bavarian Nordic A/S RECOMBINANT MODIFIED saRNA (VRP) FOR CANCER VACCINE

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1202962A (en) 1982-10-19 1986-04-08 David P. Clifford Substituted n-phenyl-n'-benzoyl ureas and their use as insecticides and acaricides
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US5091309A (en) 1986-01-16 1992-02-25 Washington University Sindbis virus vectors
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5217879A (en) 1989-01-12 1993-06-08 Washington University Infectious Sindbis virus vectors
US5217889A (en) 1990-10-19 1993-06-08 Roninson Igor B Methods and applications for efficient genetic suppressor elements
WO1994017813A1 (en) 1993-02-08 1994-08-18 Paravax, Inc. Defective sindbis virus vectors that express toxoplasma gondii p30 antigens
DE69434931T2 (de) 1993-04-02 2007-11-22 Rigel Pharmaceuticals, Inc., South San Francisco Methode zur selektiven inaktivierung der viralen replication
US5536637A (en) 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
US5824485A (en) * 1995-04-24 1998-10-20 Chromaxome Corporation Methods for generating and screening novel metabolic pathways
US5792462A (en) * 1995-05-23 1998-08-11 University Of North Carolina At Chapel Hill Alphavirus RNA replicon systems
EP0877752B1 (de) * 1996-01-23 2003-05-21 The Board Of Trustees Of The Leland Stanford Junior University Verfahren zur suche nach transdominanten effektorpeptiden und rna-molekülen
US5783431A (en) * 1996-04-24 1998-07-21 Chromaxome Corporation Methods for generating and screening novel metabolic pathways

Also Published As

Publication number Publication date
US6197502B1 (en) 2001-03-06
EP0972086A1 (de) 2000-01-19
ATE407219T1 (de) 2008-09-15
AU760584B2 (en) 2003-05-15
EP0972086B1 (de) 2008-09-03
WO1999025876A1 (en) 1999-05-27
EA199900668A1 (ru) 2000-06-26
NO994220D0 (no) 1999-08-31
EP0972086A4 (de) 2005-07-20
DE69839962D1 (de) 2008-10-16
CA2282811A1 (en) 1999-05-27
AU1415599A (en) 1999-06-07
IL131759A0 (en) 2001-03-19
NZ337297A (en) 2001-03-30
US6524792B1 (en) 2003-02-25

Similar Documents

Publication Publication Date Title
NO994220D0 (no) Ekspresjonskloningsmetoder for oppdagelse, karakterisering og isolering av gener som koder for polypeptider med en pÕ forhÕnd bestemt egenskap
DE3588255D1 (de) Klonierung und Expression von HTLV-III-DNS
ATE448246T1 (de) Sekretierte und transmembran-polypeptide sowie nukleinsäuren zu deren kodierung
BG100771A (bg) Хематопоетичен протеин и материали и методи за неговото получаване
WO1999028462A3 (en) Polypeptides and nucleic acids encoding the same
AU3774300A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1027437B8 (de) Verwendung des wnt-1 induzierten sekretierten polypeptids wisp-1
WO1999006557A3 (en) Mammalian cell membrane proteins; related reagents
BR0009393A (pt) Polipeptìdeo, sequência de ácido nucleico isolada, construção de ácido nucleico, vetor de expressão recombinante, célula hospedeira recombinante, método para a produção do polipeptìdeo, uso de um polipeptìdeo, e, composição detergente
DK1616878T3 (da) Udskilte og membranspændende polypeptider samt nukleinsyrer kodende for disse
ATE498013T1 (de) Für zellzyklusproteine kodierende nukleinsäure und deren verwendung
DE69117123D1 (de) Menschliches MK Gen und Protein-Sequenz
FI911882A0 (fi) Foerfarande foer framstaellning av fraemmande proteiner i streptomyceter.
DK0805204T3 (da) Bitestikel - specifikt receptorprotein og anvendelse heraf
DK1032683T3 (da) Polypeptider med 5-aminolevulinsyre-syntase-aktivitet og nukleinsyrer, der koder for disse
WO1997031612A3 (en) Mammalian endonuclease iii, and diagnostic and therapeutic uses thereof
ATE268820T1 (de) Herstellung von heterloge proteine
ATE354663T1 (de) Eine mycobacterium tuberculosis kodierende sequenz zur expression von heterologen proteinen
WO2002004601A3 (en) Mammalian mdm2 binding proteins and uses thereof
DK1241180T3 (da) Humant A33 antigen-lignende protein og nucleinsyrer, der koder for dette
Davis et al. Separation of protein-secreting from other membrane domains of Bacillus subtilis.
Kopp et al. The informational structure of DNA, RNA, and amino acid sequences
DK1241251T3 (da) Humant prostasin-lignende protein og nukleinsyrer kodende for samme
DK1217006T3 (da) Polypeptider og nucleinsyrer kodende for samme
ECSP993285A (es) Sintesis recombinante de beta lipotropina y otros peptidos